Latest Headlines

Latest Headlines

Japan looks for ways to maintain prices on older drugs

Japanese health officials say they are looking at new ways to help drug companies maintain prices on older, established medicines that are still effective but at risk of being supplanted by newer, more expensive compounds, according to a Japan News report.

Tops in generics, but India may miss the boat on biosimilars

India's ability to copy chemical-based drugs has been the foundation of the country's $15 billion pharmaceuticals industry, but its inability to produce more complex biological drugs at scale means regions like South Korea, the United States and Europe are already well ahead in the race, according to a report by the  Economic Times.

China's State Council urges Suzhou Industrial Park to be more innovative

China's State Council approved a plan this week submitted by the Jiangsu provincial government and the Ministry of Commerce for a pilot program in the China-Singapore Suzhou Industrial Park, which is already home to several pharmaceutical production plants and research facilities.

Reports: Chinese firm to spend $315M on Ebola vaccine manufacturing plant

Despite the West Africa Ebola epidemic's tapering off, a Chinese firm says it will invest $315 million into a facility in Tianjin to mass produce an Ebola vaccine developed by a group out of China's Academy of Military Medical Sciences, Reuters

Indian government upping penalties for pharma manufacturing lapses

The Indian government may be upping the ante for drugmakers that fail to follow new guidelines by doubling the penalties it imposes when manufacturing plants attract the ire of international regulators, according to a report in the Hindustan Times.

Myanmar trying to move up the food chain on pharma production

Myanmar is trying to kick-start its pharmaceutical manufacturing industry, which currently consists of a handful of state-owned factories and one public-private joint venture, to wean itself off foreign imports, according to a recent report on the Frontier Myanmar news website.

U.S. FDA approvals for Indian pharmas jump 50%

Indian pharmaceutical firms got some good news last week when it was reported that during the period from July to September there was a 50% gain in the number of abbreviated new drug approvals (ANDAs) by the U.S. FDA, Bloomberg TV India reported.

Indian drugmakers take page from HIV playbook for hep C combo pill

Indian drug manufacturers are working to combine drugs used to treat hepatitis C in ways not possible in the West because of patent restrictions, according to a Bloomberg News report.

Ruling on Merck diabetes drug shows domestic firms not favored in India courts

Dilip Shah, secretary-general of the Indian Pharmaceutical Alliance, said this week's decision by the Delhi High Court against homegrown Glenmark Pharmaceuticals showed "due process was followed" and that Indian companies could not count on Indian courts for special treatment, according to a report in the Wall Street Journal.

China's BeiGene snaps up Pfizer executive to run manufacturing ops

China oncology biotech BeiGene has snapped up Changzhen Wu to head a manufacturing operation that is in the process of outfitting a major facility in Suzhou, building on another key hire snatched from WuXi AppTec to build out a formidable team.